These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21188835)

  • 21. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Cohn JN
    J Appl Physiol (1985); 2010 Dec; 109(6):2006-7. PubMed ID: 21188834
    [No Abstract]   [Full Text] [Related]  

  • 22. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans.
    Kobori H; Fu Q; Crowley SD; Gonzalez-Villalobos RA; Campos RR
    J Appl Physiol (1985); 2010 Dec; 109(6):2003. PubMed ID: 21148352
    [No Abstract]   [Full Text] [Related]  

  • 23. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Intrarenal angiotensin II generation as a hypertensinogenic mechanism.
    Gonzalez-Villalobos RA; Fuchs S
    J Appl Physiol (1985); 2010 Dec; 109(6):2013. PubMed ID: 21188829
    [No Abstract]   [Full Text] [Related]  

  • 24. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Systemic hypertension--involvement of the CNS to this complex puzzle.
    Moreira TS; Takakura AC; Antunes VR
    J Appl Physiol (1985); 2010 Dec; 109(6):2004. PubMed ID: 21188814
    [No Abstract]   [Full Text] [Related]  

  • 25. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. AT1 receptors in the kidney mediate the chronic hypertensive response to angiotensin II.
    Crowley SD
    J Appl Physiol (1985); 2010 Dec; 109(6):2012-3. PubMed ID: 21188828
    [No Abstract]   [Full Text] [Related]  

  • 26. Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension.
    Navar LG
    J Appl Physiol (1985); 2010 Dec; 109(6):1998-2000; discussion 2015. PubMed ID: 21148349
    [No Abstract]   [Full Text] [Related]  

  • 27. Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.
    Esler M; Lambert E; Schlaich M
    J Appl Physiol (1985); 2010 Dec; 109(6):1996-8; discussion 2016. PubMed ID: 20185633
    [No Abstract]   [Full Text] [Related]  

  • 28. Rebuttal from Esler, Lambert, and Schlaich.
    Esler M; Lambert E; Schlaich M
    J Appl Physiol (1985); 2010 Dec; 109(6):2000-1. PubMed ID: 21148350
    [No Abstract]   [Full Text] [Related]  

  • 29. Rebuttal from Navar.
    Navar LG
    J Appl Physiol (1985); 2010 Dec; 109(6):2001-2. PubMed ID: 21148351
    [No Abstract]   [Full Text] [Related]  

  • 30. The sympathetic nervous system and hypertension: recent developments.
    DiBona GF
    Hypertension; 2004 Feb; 43(2):147-50. PubMed ID: 14707153
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanisms mediating renal sympathetic nerve activation in obesity-related hypertension.
    Chen W; Leo S; Weng C; Yang X; Wu Y; Tang X
    Herz; 2015 Apr; 40 Suppl 2():190-6. PubMed ID: 24609799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity and insulin resistance in resistant hypertension: implications for the kidney.
    Rao A; Pandya V; Whaley-Connell A
    Adv Chronic Kidney Dis; 2015 May; 22(3):211-7. PubMed ID: 25908470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiology of obesity hypertension.
    Hall JE
    Curr Hypertens Rep; 2000 Apr; 2(2):139-47. PubMed ID: 10981140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leptin and hypertension in obesity.
    Bravo PE; Morse S; Borne DM; Aguilar EA; Reisin E
    Vasc Health Risk Manag; 2006; 2(2):163-9. PubMed ID: 17319461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salt-Sensitive Hypertension and the Kidney.
    Nishimoto M; Griffin KA; Wynne BM; Fujita T
    Hypertension; 2024 Jun; 81(6):1206-1217. PubMed ID: 38545804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions between the sympathetic nervous system and angiotensin system in renovascular hypertension.
    Pradhan N; Rossi NF
    Curr Hypertens Rev; 2013 May; 9(2):121-9. PubMed ID: 23971694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel interaction between sympathetic overactivity and aberrant regulation of renin by miR-181a in BPH/2J genetically hypertensive mice.
    Jackson KL; Marques FZ; Watson AM; Palma-Rigo K; Nguyen-Huu TP; Morris BJ; Charchar FJ; Davern PJ; Head GA
    Hypertension; 2013 Oct; 62(4):775-81. PubMed ID: 23897069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The kidney, hypertension, and obesity.
    Hall JE
    Hypertension; 2003 Mar; 41(3 Pt 2):625-33. PubMed ID: 12623970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex Differences in Mechanisms of Hypertension Associated With Obesity.
    Faulkner JL; Belin de Chantemèle EJ
    Hypertension; 2018 Jan; 71(1):15-21. PubMed ID: 29133358
    [No Abstract]   [Full Text] [Related]  

  • 40. [Obesity and hypertension].
    Simonyi G; Kollár R
    Orv Hetil; 2013 Nov; 154(44):1736-42. PubMed ID: 24161597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.